Any type of cancer · adult men and women who had been exposed to arsenic‐containing drinking water
1 finding from 1 review
All‐cause mortality · adult men and women who had been exposed to arsenic‐containing drinking water
1 finding from 1 review
Neurocognitive function · adult men and women who had been exposed to arsenic‐containing drinking water
1 finding from 1 review
Any congenital anomalies · adult men and women who had been exposed to arsenic‐containing drinking water
1 finding from 1 review
Blood arsenic Measured by change in total blood arsenic, InAs, MMA, and DMA from baseline to week 12 · adult men and women who had been exposed to arsenic‐containing drinking water
1 finding from 1 review
Urinary arsenic Measured by change in percentage (%) of InAs, MMA, and DMA from baseline to week 12 · adult men and women who had been exposed to arsenic‐containing drinking water
1 finding from 1 review
Plasma homocysteine Measured by change in GM of plasma homocysteine concentrations from baseline to week 12 · adult men and women who had been exposed to arsenic‐containing drinking water
1 finding from 1 review
Live birth · obese women with subfertility
Non‐pharmacological intervention showed no clear difference in live birth compared with no intervention or placebo (low certainty).
1 finding from 1 review
Live birth · obese women with subfertility
It is very uncertain whether pharmacological intervention changes live birth compared with no intervention or placebo (very low certainty).
1 finding from 1 review
Ongoing pregnancy · obese women with subfertility
Non‐pharmacological intervention showed no clear difference in ongoing pregnancy compared with no intervention or placebo (low certainty).
1 finding from 1 review
Ongoing pregnancy · obese women with subfertility
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Miscarriage · obese women with subfertility
It is very uncertain whether pharmacological intervention changes miscarriage compared with no intervention or placebo (very low certainty).
1 finding from 1 review
Adverse events (GI) · obese women with subfertility
It is very uncertain whether pharmacological intervention changes adverse events (GI) compared with no intervention or placebo (very low certainty).
1 finding from 1 review
Clinical pregnancy · obese women with subfertility
It is very uncertain whether pharmacological intervention changes clinical pregnancy compared with no intervention or placebo (very low certainty).
1 finding from 1 review
Weight changeBMI WHR · obese women with subfertility
1 finding from 1 review
Quality of life/Mental health outcome · obese women with subfertility
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Miscarriage · obese women with subfertility
It is very uncertain whether non‐pharmacological intervention changes miscarriage compared with no intervention or placebo (very low certainty).
1 finding from 1 review
Clinical pregnancy · obese women with subfertility
Non‐pharmacological intervention showed no clear difference in clinical pregnancy compared with no intervention or placebo (low certainty).
1 finding from 1 review
Weight changeBMI change (Einarsson 2017) · obese women with subfertility
1 finding from 1 review
Change in BMI · obese women with subfertility
1 finding from 1 review